DOTI, NUNZIANNA
 Distribuzione geografica
Continente #
AS - Asia 2.056
NA - Nord America 1.480
EU - Europa 616
SA - Sud America 424
Continente sconosciuto - Info sul continente non disponibili 222
AF - Africa 37
OC - Oceania 1
Totale 4.836
Nazione #
US - Stati Uniti d'America 1.409
SG - Singapore 821
CN - Cina 496
BR - Brasile 328
HK - Hong Kong 235
IT - Italia 224
VN - Vietnam 214
FR - Francia 132
KR - Corea 82
NL - Olanda 54
GB - Regno Unito 42
BD - Bangladesh 41
FI - Finlandia 40
DE - Germania 35
CA - Canada 32
JP - Giappone 32
AR - Argentina 31
IN - India 28
EC - Ecuador 18
ID - Indonesia 18
MX - Messico 17
PL - Polonia 15
ZA - Sudafrica 15
RU - Federazione Russa 14
CO - Colombia 12
PY - Paraguay 11
TR - Turchia 11
IL - Israele 10
IQ - Iraq 10
SE - Svezia 9
VE - Venezuela 9
UZ - Uzbekistan 8
UA - Ucraina 7
ES - Italia 6
MY - Malesia 6
NP - Nepal 6
PK - Pakistan 6
CR - Costa Rica 5
KE - Kenya 5
PE - Perù 5
TT - Trinidad e Tobago 5
AM - Armenia 4
AT - Austria 4
CL - Cile 4
CZ - Repubblica Ceca 4
IE - Irlanda 4
NG - Nigeria 4
PH - Filippine 4
SA - Arabia Saudita 4
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
PT - Portogallo 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
LT - Lituania 2
MA - Marocco 2
MM - Myanmar 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
DM - Dominica 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
RW - Ruanda 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
Totale 4.614
Città #
Singapore 496
Santa Clara 274
Hong Kong 228
San Jose 153
Hefei 149
Ashburn 99
Council Bluffs 95
Lauterbourg 92
Beijing 91
Seoul 80
Ho Chi Minh City 70
Los Angeles 62
Hanoi 43
Naples 37
Dallas 26
São Paulo 26
New York 24
Lappeenranta 23
Princeton 22
Frankfurt am Main 20
Rome 18
Tokyo 18
Casandrino 17
Helsinki 16
Buffalo 14
Abbeville 13
Amsterdam 12
Brasília 12
Milan 12
Atlanta 11
Rio de Janeiro 11
Shenzhen 11
Baltimore 10
Da Nang 10
Haiphong 10
Minamishinagawa 10
Philadelphia 10
Afragola 9
Bengaluru 9
Curitiba 9
Florence 9
Johannesburg 9
Orem 9
Chicago 8
Montreal 8
Phoenix 8
Pozzuoli 8
Tashkent 8
Asunción 7
Belo Horizonte 7
Manchester 7
Portsmouth 7
San Francisco 7
Wroclaw 7
Bologna 6
Can Tho 6
Cincinnati 6
Dhaka 6
Guayaquil 6
Las Vegas 6
Warsaw 6
Americana 5
Baghdad 5
Biên Hòa 5
Dublin 5
Miami 5
Munich 5
Poplar 5
Providence 5
Quito 5
Rochester 5
San José 5
The Bronx 5
Bari 4
Bauru 4
Bexley 4
Boston 4
Brooklyn 4
Diadema 4
Düsseldorf 4
Elk Grove Village 4
Lấp Vò 4
Nairobi 4
Newark 4
Nha Trang 4
Nuremberg 4
Paris 4
Porto Alegre 4
Prague 4
Santos 4
Springfield 4
Stockholm 4
São Bernardo do Campo 4
Turin 4
Vienna 4
Yerevan 4
Abuja 3
Almaty 3
Amman 3
Austin 3
Totale 2.667
Nome #
SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection 87
Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy 86
Recent applications of retro-inverso peptides 85
Targeting Protein-Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches 81
Design, synthesis, structural analysis and biochemical studies of stapled AIF (370-394) analogues as ligand of CypA 81
Novel N-Phenyl-Substituted Thiazolidinediones Protect Neural Cells against Glutamate- and tBid-Induced Toxicity 77
A Comprehensive Analysis of the Intrinsic Visible Fluorescence Emitted by Peptide/Protein Amyloid-like Assemblies 76
A peptide from the N-terminal region of PED/PEA-15 blocks its interaction with PLD1 and restores insulin sensitivity in skeletal muscle cells . 75
Design, Optimization, and Structural Characterization of an Apoptosis-Inducing Factor Peptide Targeting Human Cyclophilin A to Inhibit Apoptosis Inducing Factor-Mediated Cell Death 74
Melittin-Related Peptides Interfere with Sandfly Fever Naples Virus Infection by Interacting with Heparan Sulphate 72
Expression, Purification, Structural and Functional Characterization of Recombinant Human Parvulin 17 71
Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry 71
Molecular basis of the PED/PEA15 interaction with the C-terminal fragment of phospholipase D1 revealed by NMR spectroscopy 68
The Characterization of Multifaceted PREP1 Peptides Provides Insights into Correlations between Spectroscopic and Structural Properties of Amyloid-like Assemblies 66
Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine 63
Hylin-a1: A Host Defense Peptide with Antibacterial Potential against Staphylococcus aureus Multi-Resistant Strains 63
Synthetic Peptide Libraries. From random mixtures to in vivo testing. 62
Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications-Second Edition 60
Design and Synthesis of Oligopeptidic Parvulin Inhibitors 60
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein 60
Protein-protein interactions and peptide antagonists 59
A recent update on the use of microbial transglutaminase for the generation of biotherapeutics 59
The antiherpetic and anti-inflammatory activity of the frog-derived peptide Hylin-a1 58
Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications. 57
Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe 56
A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cells 56
A comparative analysis of catalytic activity and stability of microbial transglutaminase in controlled denaturing conditions 55
Design of Three Residues Peptides against SARS-CoV-2 Infection 55
Oreoch-1: A Peptide from Oreochromis niloticus as a Potential Tool against Staphylococci 55
Hylin-a1: A Pan-Inhibitor against Emerging and Re-Emerging Respiratory Viruses 54
Expression and purification of the D4 region of PLD1 and characterization of its interaction with PED-PEA15 53
Amyloid-like Prep1 peptides exhibit reversible blue-green-red fluorescence in vitro and in living cells 53
A multianalytical approach to investigate the effect of nanofiltration on plasma-derived factor IX clinical lots 52
Oreoch‐1: A broad‐spectrum virus and host‐targeting peptide against animal infections 52
Outer Membrane Vesicles Derived from Klebsiella pneumoniae Are a Driving Force for Horizontal Gene Transfer 52
FRET-Protease-Coupled Peptidyl-Prolyl cis-trans Isomerase Assay: New Internally Quenched Fluorogenic Substrates for High-Throughput Screening 52
Synthetic Frog-Derived-like Peptides: A New Weapon against Emerging and Potential Zoonotic Viruses 52
Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells 51
Evaluation of combined use of Oxyma and HATU in aggregating peptide sequences 50
Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43 50
Interleukin 6 reduces vascular smooth muscle cell apoptosis via Prep1 and is associated with aging 49
The Interacting Domains of PREP1 and p160 are Endowed with a Remarkable Structural Stability 48
Monoacylglycerides from the Diatom Skeletonema marinoi Induce Selective Cell Death in Cancer Cells 48
Identification of Inhibitors of Protein-Protein Interactions Through the Screening of Simplified Combinatorial Peptide Libraries. Breaking Away: Proceedings of the 21st American Peptide Symposium Michal Lebl 47
Side Reaction Analysis in Solid-Phase Peptide Synthesis: A Case Study in the Glu–Asp–Tyr Motif 47
Binding mode of AIF(370-394) peptide to CypA: insights from NMR, label-free and molecular docking studies 47
Structural and biochemical insights of CypA and AIF interaction 47
New mimetic peptides of Kinase Inhibitory Region (KIR) of SOCS1through focused peptide libraries 46
Development and characterization of a membrane-permeant GRASP65-mimetic peptide that inhibits Golgi unlinking and cell cycle progression 46
Discovery ofsmall peptide antagonists of PED/PEA15-D4? interaction from simplifiedcombinatorial libraries 45
Selective disruption of insulin-like growth factor (IGF)-1 signalling via phosphoinositide-dependent kinase-1 prevents the protective effect of IGF-1 on human cancer cell death. 44
The Broad-Spectrum Antiviral Potential of the Amphibian Peptide AR-23 43
A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cells 43
Peptide antagonists of the PED-hPLD1 binding 41
Relevance and therapeutic potential of CypA targeting to block apoptosis inducing factor-mediated neuronal cell death 40
A targeted secretome profiling by multiplexed immunoassay revealed that secreted chemokine ligand 2 (MCP-1/CCL2) affects neural differentiation in mesencephalic neural progenitor cells 40
Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy 40
Mapping the native interaction surfaces of PREP1 with PBX1 by cross-linking mass-spectrometry and mutagenesis 40
Prep1 regulates angiogenesis through a PGC-1?-mediated mechanism 39
Automatic procedures for the synthesis of difficult peptides using oxyma as activating reagent: A comparative study on the use of bases and on different deprotection and agitation conditions 39
The inhibitory potential of three scorpion venom peptides against multidrug-resistant Klebsiella pnemoniae 39
Trifluoroacetylated tyrosine-rich D-tetrapeptides have potent antioxidant activity 37
Peptide mimics of the IgE high affinity receptor Fc?RI?. 36
Peptide mimics of the IgE high affinity receptor FceRIa 36
NMR backbone dynamics studies of human PED/PEA-15 outline protein functional sites 36
Generation and characterization of monoclonal antibodies against a cyclic variant of hepatitis C virus E2 epitope 412-422 36
Pantinin‐Derived Peptides against Veterinary Herpesviruses: Activity and Structural Characterization 36
Interaction between AIF and CHCHD4 Regulates Respiratory Chain Biogenesis 35
CHCHD4 Oxidoreductase Activity: A Comprehensive Analysis of the Molecular, Functional, and Structural Properties of Its Redox-Regulated Substrates 35
Residues 762-801 of PLD1 mediate the interaction with PED/PEA15 34
An analysis of deletion mutants of the PLD1 D4 domain defines short regions within the PLD1 interacting with PED/PEA15: implications for the development of peptides-specific antagonist. 33
Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion 33
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment 32
An analysis of deletion mutants of the PLD1D4 domain defines short regions within the PLD1 interacting with PED/PEA15: implications for the development of peptide specific antagonists. 32
Synthetic peptide ligands for alfa1AT 31
Expression, purification and characterization of h-Gadd45â 31
Structural versatility of Hepatitis C virus proteins: Implications for the design of novel anti-HCV intervention strategies 30
An analysis of deletion mutants of the PLD1 D4 domain defines short regions within the PLD1 interacting with PED/PEA-15: implications for the development of peptides-specific antagonist. 30
Peptide antagonists of protein-protein interactions identified by screening protein fragments derived by enzyme degradation 29
Synthetic peptide ligands for a1AT 29
Few residues to inhibit VEGF receptors. Chemistry towards 29
Peptide antagonists of the PED-hPLD1 29
Mimetic peptides of suppressor of cytokine signaling (SOCS)1 impair inflammatory responses of epidermal keratinocytes in vitro and in a mouse skin model of allergic contact dermatitis 28
Identification of Protease Inhibitors by a Fast Fluorimetric Assay 28
Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death 28
Activation of KCNN3/SK3/KCa2.3 channels attenuates enhanced calcium influx and inflammatory cytokine production in activated microglia 28
Expanding the Antiviral Spectrum of Scorpion-Derived Peptides Against Toscana Virus and Schmallenberg Virus 27
An analysis of deletion mutants of the PLD1 D4 domain defines short regions within the PLD1 interacting with PED/PEA15: implications for the development of peptides-specific antagonist 27
Structure–Function Insights into Frog Skin Peptides Reveal Potent Inhibition of West Nile Virus Entry 27
Structural analysis of cyclopeptides against VEGF- Receptor A 27
Discovery of Small Peptide Antagonists of PED/PEA15-D4 alpha Interaction from Simplified Combinatorial Libraries 27
Peptide Antagonists of Protein-Protein Interactions Identified by Screening Protein Fragments 27
Determinants of Chain Selection and Staggering in Heterotrimeric Collagens: A Comprehensive Review of the Structural Data 26
Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses 26
Inhibiting the interaction between apoptosis-inducing factor and cyclophilin A prevents brain injury in neonatal mice after hypoxia-ischemia 26
Antagonists of Gadd45beta-MKK7 interaction by screening of a synthetic peptide library 26
Expression, purification and characterization of Gadd45? 26
Frog Skin Peptides Hylin-a1, AR-23, and RV-23: Promising Tools Against Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae Infections 25
The thiol-disulfide oxidoreductase system in the cold-adapted bacterium Pseudoalteromonas haloplanktis TAC 125: discovery of a novel disulfide oxidoreductase enzyme 25
Peptide antagonists of protein-protein interactions identified by screening protein fragments derived by enzyme degradation . 25
Totale 4.605
Categoria #
all - tutte 16.371
article - articoli 14.209
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202432 0 0 0 0 0 0 0 0 0 0 23 9
2024/20251.602 11 4 274 61 245 91 8 67 73 113 360 295
2025/20262.370 108 215 238 318 398 162 376 137 139 141 83 55
2026/2027832 135 103 336 258 0 0 0 0 0 0 0 0
Totale 4.836